Dose finding study with irinotecan (CPT-11) in previously treated colo-rectal cancer

被引：0
|
作者：
Viéitez, JM
Carrasco, J
Fra, J
Muñiz, I
Esteban, E
Palacio, I
Sala, M
Puertas, J
Estrada, E
Buesa, JM
Lacave, AJ
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Phase I dose finding study with irinotecan (CPT-11) in cancer patients (pts) with hepatic dysfunction
    Raymond, E
    Vernillet, L
    Boige, V
    Hua, A
    Ducreux, M
    Mekhaldi, S
    Jacques, C
    Gatineau, M
    Mignard, D
    Vergniol, JC
    Armand, JP
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S283 - S284
  • [2] First- and second-line treatment of metastatic colo-rectal cancer (MCRC) with high-dose irinotecan (CPT-11): A monocentric institution safety analysis of 46 patients
    Mineur, L.
    Keischer, S.
    Goubely, Y.
    Molinari, N.
    Werner, H.
    ANNALS OF ONCOLOGY, 2007, 18 : VII80 - VII81
  • [3] Neoadjuvant radiochemotherapy with irinotecan (CPT-11) and capecitabine in locally advanced rectal cancer
    Kraus-Tiefenbacher, U
    Hofheinz, R
    von Gerstenberg-Heffdorf, B
    Willeke, F
    Hochhaus, A
    Wenz, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 31 - 31
  • [4] Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy
    Aravantinos, G
    Skarlos, DV
    Kosmidis, P
    Georgoulias, V
    Sgouros, I
    Bafaloukos, D
    Androulakis, N
    Florou, S
    Fountzilas, G
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (03) : 209 - 219
  • [5] PHASE II STUDY OF IRINOTECAN (CPT-11) IN PATIENTS (PTS) WITH PREVIOUSLY TREATED METASTATIC BREAST CANCER (MBC): KMBOG0601
    Hayashi, H.
    Tsurutani, J.
    Satoh, T.
    Sakamoto, J.
    Masuda, N.
    Tokunaga, Y.
    Yamaguchi, M.
    Tominaga, S.
    Fukuoka, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 121 - 121
  • [6] Irinotecan (CPT-11) metabolism and disposition in cancer patients
    Sparreboom, A
    de Jonge, MJA
    de Bruijn, P
    Brouwer, E
    Nooter, K
    Loos, WJ
    van Alphen, RJ
    Mathijssen, RHJ
    Stoter, G
    Verweij, J
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2747 - 2754
  • [7] A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
    Rothenberg, ML
    Cox, JV
    DeVore, RF
    Hainworth, JD
    Pazdur, R
    Rivkin, SE
    Macdonald, JS
    Geyer, CE
    Sandbach, J
    Wolf, SL
    Mohrland, JS
    Elfring, GL
    Miller, LL
    Von Hoff, DD
    CANCER, 1999, 85 (04) : 786 - 795
  • [8] Dose-finding study of biweekly administration of irinotecan (CPT-11)→5FU+6S-Leucovorin (ILV) in colorectal cancer
    Casaretti, R
    Catalano, G
    Comella, P
    De Vita, F
    Avallone, A
    Orditura, M
    Palaia, R
    Comis, S
    Faranda, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 41 - 41
  • [9] A multicenter dose-finding study of irinotecan (CPT-11) based on UGT1A1 polymorphisms for metastatic colorectal cancer.
    Sato, Hirohiko
    Shimada, Mitsuo
    Kurita, Nobuhiro
    Iwata, Takashi
    Yoshikawa, Kozo
    Miyatani, Tomohiko
    Kashihara, Hideya
    Mikami, Chie
    Matsumoto, Noriko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Irinotecan Hydrochloride (CPT-11) in Dialysis Patients with Gastrointestinal Cancer
    Ashizawa, Tatsuto
    Iwahori, Tohru
    Yokoyama, Takayoshi
    Kihara, Yuu
    Konnno, Osamu
    Jyojima, Yoshimaro
    Akashi, Isao
    Nakamura, Yuuki
    Hama, Kouichirou
    Iwamoto, Hitoshi
    Segawa, Mai
    Takeuchi, Hironori
    Hirano, Toshihiko
    Nagao, Takeshi
    ACTA MEDICA OKAYAMA, 2010, 64 (01) : 19 - 26
12345